Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Three projects from MSD were amongst 10 from across the University to receive funding from the second-round of the Public Engagement with Research Seed Fund [http://www.ox.ac.uk/research/public-engagement/support-researchers].

Dr Marta Valente Pinto, is based in the Oxford Vaccine Group, part of the Department of Paediatrics, where she studies Whooping cough, a highly contagious respiratory disease that, although to some extent preventable by vaccines, continues to cause a significant number of infections in developed countries. Her project will involve the creation and delivery of workshops in Thames Valley Primary and Secondary Schools to help children and parents understand more about the disease, and to make more informed decisions about vaccinations.

Dr Marco J. Haenssgen, based in the Centre for Tropical Medicine & Global Health, part of the Nuffield Department of Medicine, received funding  to evaluate the process and impact of health-themed science theatre as part of ongoing public engagement activities at the Mahidol Oxford Tropical Medicine Research Unit. In order to engage the public with its research, MORU is collaborating with B-floor Theatre to produce a performance entitled Fishy Clouds, which explores antimicrobial resistance through puppet plays for both children and adults in Thailand. The social outcomes of drama performances are difficult to evaluate and little guidance exists in the evaluation research literature. This project will test out methods for evaluation, and in doing so inform the theory and practice of evaluating such engagement activities for others. 

Simon Knight, based at the Oxford Transplant Centre, part of the Nuffield Department of Surgical Sciences, was awarded funding to develop an online patient advisory panel for renal and transplant research in Oxford, which will provide a patient perspective on upcoming research projects and patient materials.

Similar stories

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

Oral paratyphoid vaccine to begin human trials

The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

Oxford to work with Brazil to establish clinical research hub

The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.

Vaccine for TB receives a $1.5 million funding boost

The Oxford-run VALIDATE Network has received $1.5 million in funding for its tuberculosis vaccine work from the Bill & Melinda Gates Foundation.

University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships

Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.